Cannara Biotech Inc.

TSXV LOVE.V

Cannara Biotech Inc. Return on Equity (ROE) for the year ending August 31, 2024: 7.32%

Cannara Biotech Inc. Return on Equity (ROE) is 7.32% for the year ending August 31, 2024, a -15.95% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • Cannara Biotech Inc. Return on Equity (ROE) for the year ending August 31, 2023 was 8.71%, a 152.12% change year over year.
  • Cannara Biotech Inc. Return on Equity (ROE) for the year ending August 31, 2022 was 3.45%, a 171.58% change year over year.
  • Cannara Biotech Inc. Return on Equity (ROE) for the year ending August 31, 2021 was -4.83%, a 86.59% change year over year.
  • Cannara Biotech Inc. Return on Equity (ROE) for the year ending August 31, 2020 was -35.99%, a -22.76% change year over year.
Key data
Date Return on Equity (ROE) Return on Capital Employed (ROCE) Interest Coverage Ratio Debt to Equity Ratio
Market news
SV Wall Street
TSXV: LOVE.V

Cannara Biotech Inc.

CEO Mr. Zohar Krivorot
IPO Date Jan. 14, 2019
Location Canada
Headquarters 333 Decarie Blvd.
Employees 461
Sector Consumers Staples
Industries
Tobacco Alcoholic Beverages Bread & Bakery Cosmetics Drugstores & Retail Pharmacies Perfumes & Fragrances Personal Care
Description

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. It also offers hemp-based CBD products through e-commerce platform. The company was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.

StockViz Staff

February 6, 2025

Any question? Send us an email